*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Saxagliptin intermediate (SGA) is a critical pharmaceutical building block for the synthesis of <strong>sitagliptin</strong> analogs. Produced via asymmetric hydrogenation or chiral resolution, it ensures high optical purity. Its standard molecular formula is <strong>C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub></strong> with CAS No. <strong>864009-38-1</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Key precursor for anti-diabetic DPP-4 inhibitors.</li>
<li><strong>R&D Laboratories:</strong> Used in process optimization and impurity profiling studies.</li>
<li><strong>Contract Manufacturing:</strong> Sourced by CDMOs for API bulk production.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at 2-8°C to prevent degradation. Handle with appropriate PPE to avoid skin contact; inhalation risks exist during powder handling. Regulatory compliance requires strict batch traceability for clinical use.</p>